Immediate Impact

56 standout
Sub-graph 1 of 24

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease
2024 Standout
2 intermediate papers

Works of Jiao Sang being referenced

Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
2016
Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma
2016

Author Peers

Author Last Decade Papers Cites
Jiao Sang 105 82 176 142 16 377
Clémence Hollande 91 66 97 82 19 344
Tai-Jay Chang 62 62 102 61 18 373
Pablo Sáenz-López 51 37 165 140 14 395
Naizhou Guo 50 68 134 139 11 368
Xinxia Feng 97 78 68 88 17 358
Jing Lu 65 25 86 139 21 376
Xiaoxin Mu 83 64 100 85 18 441
Harald E. Fischer 82 61 93 62 21 425
Tomoe Shimazaki 169 214 94 66 21 440
Palma Aurelia Iacovazzi 62 47 55 105 22 343

All Works

Loading papers...

Rankless by CCL
2026